{"sourcedb":"DevicePMAs@therightstef","sourceid":"N50510_S144","text":"Approval for the addition of the antibiotic quinupristin/dalfopristin at concentrations of 0.75, 1.5, and 3 mcg/ml to the vitek. gram positive susceptibility panel.  The device will be marketed under the trade name vitek. gram positive susceptibility (gps) card for quinupristin/dalfopristin, and is indicated for use in vitek. gram positive susceptibility test cards for the susceptibility testing of methicillin-susceptible staphylococcus aureus,  vancomycin-resistant enterococcus faecium, staphylococcus epidermidis, and streptococcus agalactiae isolate to quinupristin/dalfopristin in the range of \u003C=.5 to \u003E=4 mcg/ml.","project":"consensus_PMA_Age_Indications"}